Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Why Is Zhibao Technology (ZBAO) Stock Down -24.52% Today?

Why Is Zhibao Technology (ZBAO) Stock Down -24.52% Today?

Key Takeaways

  • ZBAO fell 24.52% to $0.2109, down from Friday's close of $0.2794, unwinding the prior session's 32.54% post-earnings jump.
  • The primary driver is profit-taking and a hard second look at fiscal 2026 results that merely met guidance the company had already telegraphed.
  • Secondary pressure comes from the annual report's going-concern language, negative working capital, and heavy share dilution from the $154.7 million Bitcoin-settled private placement and convertible notes.
  • Broader context is unhelpful: U.S. indices opened sharply lower, semiconductors led the decline, and China ADRs traded broadly weaker.
  • News Significance Score: 34/100 — moderate annual-report disclosures met an unusually large but familiar two-and-three-quarter-times-normal price swing.
  • Traders are watching whether the shares can hold the $0.19 area that marked the 52-week low and whether the company regains Nasdaq bid-price compliance.
  • Deeper detail on Price Targets, Earnings and Forecast data is available on Tickeron's dedicated pages.
  • Explore Trending AI Robots to see which automated strategies are outperforming in the current tape.

ZBAO Shares Give Back Friday's Post-Earnings Surge

Zhibao Technology Inc. (ZBAO) is a Shanghai-based InsurTech group that sells digital embedded insurance through a 2B2C model, embedding policies into internet platforms, enterprise channels, utilities and government programs, alongside managing general underwriter services. The micro-cap stock fell 24.52% on Monday, trading at $0.2109 against a prior close of $0.2794, after gapping down to $0.199 at the opening bell.

The direction is unambiguously negative and follows a one-session spike. On Friday the shares surged 32.54% on roughly 223 million shares — some fifty times the typical daily turnover — after the company released fiscal 2026 results and filed its annual report on Form 20-F. That buying reversed almost immediately, with the stock sliding in Friday's after-hours session and extending the decline on Monday. No fresh company release or filing arrived Monday, so the move is best understood as a post-earnings reversal rather than a reaction to new information.

Annual Results That Met, Rather Than Beat

The headline numbers were solid but pre-announced. Revenue rose 16% to RMB 319.9 million (about US$47.1 million) for the year ended June 30, 2026, exactly in line with preliminary guidance issued weeks earlier. Operating income turned positive at RMB 9.2 million after a RMB 53.5 million operating loss, and the net loss narrowed 95.3% to RMB 2.9 million. Much of that improvement came from cost discipline: selling and marketing expense fell 44.6% as the company pulled back on spending amid tight cash. With the top line already disclosed and profitability driven by cuts rather than acceleration, there was limited new upside for buyers to price in — a common setup for a fast round trip in a stock this small.

Going-Concern Doubt and a Dilution Overhang

The annual report itself carried material caveats. As of June 30, 2026, Zhibao reported negative working capital of RMB 6.9 million and an accumulated deficit of RMB 196.5 million, conditions management said raised substantial doubt about the company's ability to continue as a going concern before post-period financings. Those financings are large relative to the equity: a US$154.7 million private placement settled in 2,380 Bitcoin, plus senior secured convertible notes issued to an institutional investor. The capital structure also includes up to US$7.5 million in earn-out shares tied to the pending NEXSYS acquisition.

For a company valued at only a few million dollars, that combination — a large new share block, convertibles priced off a falling stock, and contingent issuance — keeps dilution risk front of mind. The 1-for-50 reverse split completed October 12, implemented to address Nasdaq's minimum bid price requirement, has not restored the price sustainably; the shares remain roughly 99% below their 52-week high of $67.00.

Risk-Off Tape and China ADR Weakness

Monday's macro backdrop amplified the selling. U.S. indices opened lower, with the Nasdaq down more than 1% and the S&P 500 off roughly 0.8% as semiconductor and AI-hardware names led losses. Chinese ADRs were broadly softer, with the Nasdaq Golden Dragon China Index down more than 1% intraday. Hotter producer inflation data and a 10-year Treasury yield above 5% have hardened expectations for a December rate increase — a difficult environment for unprofitable micro-caps. Zhibao's move was far larger than the tape, but the direction was consistent with it.

Market Context and Trading Activity

Volume was heavy for a normal session. Roughly half a million shares traded in the first 40 minutes, already more than the entire turnover of several sessions last week and well above the pace seen before Friday's spike, though far below Friday's extreme. Technically, the stock sits below its 50-day and 200-day moving averages around $0.24 and $1.35 respectively, and Monday's intraday low of $0.1927 came within a cent of the 52-week low of $0.1911 set on November 10. Momentum gauges had already been flashing oversold readings before the selloff resumed.

News Significance Score

The scale runs from 0, meaning no meaningful news and a routine move, to 100, meaning transformative news and an extreme, rare price swing. ZBAO scores 34 out of 100. The verified news is moderate: an annual report with improving operating results but explicit going-concern language and substantial dilution risk, already published before Monday's session. The price move was large in isolation — about 2.75 times the stock's typical absolute daily change of roughly 8.9% — yet swings of 24.5% or more occurred five times in the last 60 sessions. Strong-enough news and a familiar, if violent, move combine into a mid-range score.

What Comes Next for ZBAO

Zhibao reports on a semiannual cycle and has not announced a date for its next interim results, so the near-term focus is on disclosure rather than guidance. Investors will look for progress on the three items management cited: extensions of bank loan maturities, sustained operating cash flow, and the terms of any further capital raising. The pending NEXSYS acquisition and the Labuan reinsurance subsidiary are the most likely sources of new revenue in fiscal 2027, while the scaled-back marketing budget raises questions about growth durability. Listing compliance is another watch item — the shares must hold above Nasdaq's minimum bid threshold. Risks include continued dilution from convertibles, liquidity constraints, and the stock's well-documented tendency toward double-digit percentage swings.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated lineup drawn from hundreds of automated trading bots that cover thousands of tickers. Rather than listing the full library, it highlights only the strategies producing the strongest results under current market conditions. Bots differ widely by strategy logic, holding period, performance metrics and the specific symbols they trade, so the featured set shifts as volatility and leadership change. Visitors can compare approaches before deciding which fits their own process. Explore the Trending AI Robots section to see this week's standouts.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ZBAO

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


Momentum Indicator for ZBAO turns negative, indicating new downward trend

ZBAO saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 58 similar instances where the indicator turned negative. In 56 of the 58 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZBAO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ZBAO entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ZBAO just turned positive on October 27, 2026. Looking at past instances where ZBAO's MACD turned positive, the stock continued to rise in 27 of 31 cases over the following month. The odds of a continued upward trend are 87%.

ZBAO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ZBAO's P/B Ratio (13.624) is slightly higher than the industry average of (2.794). P/E Ratio (11.217) is within average values for comparable stocks, (19.877). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (0.074) is also within normal values, averaging (3.106).

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. ZBAO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZBAO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 16B. The market cap for tickers in the group ranges from 3.03K to 97.74B. MRSH holds the highest valuation in this group at 97.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -9%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 17%. HUIZ experienced the highest price growth at 6%, while SLQT experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 29%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 50
SMR Rating: 70
Profit Risk Rating: 85
Seasonality Score: 9 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Industry
N/A
Address
Floor 3, Building 6, Wuxing Road
Phone
+86 2150896502
Employees
137
Web
https://www.zhibao-tech.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.